\

 

 

Home About Us Contact Us

 

Table of Content - Volume 10 Issue 3 - June 2018


 

A study on association of serum uric acid levels in acute ischemic stroke patients in a tertiary level care hospital, Chennai

 

Harikrishnan J1, Sujatha S2*

 

{1Assistant Professor, Department of General Medicine} {2Assistant Professor, Department of Community Medicine}

Chengalpattu Medical College and Hospital, Chengalpattu, INDIA.

Email: jharikrishnan81@gmail.com

 

Abstract              Background: For decades the role of Uric acid as a independent risk factor for non-communicable disease is a subject of discussion. Serum Uric acid is a powerful antioxidant that scavenge many harmful free radicals like hydroxyl ions, peroxinitrite along with other anti-oxidants like ascorbic acid .But elevated serum uric acid can act as pro-oxidant that cause various inflammatory reactions .High Serum uric acid can cause endothelial dysfunction, nitric oxide reduction in cells, platelet dysfunction, vascular smooth muscle cells proliferation and activates Renin Angiotensin Aldosterone System. Objective: 1. To study the association between serum uric acid level and acute ischemic stroke patients. 2. To assess the serum uric acid level in the various risk factors of acute ischemic stroke. Methodology: This is an cross sectional study done at Government Royapettah Hospital, Chennai. After obtaining the official permission from Institutional Ethics Committee and informed consent from the patients, the study was conducted. The arrived sample size was 50. Simple random sampling done to arrive at the sample size. The Patients admitted in Govt. Royapettah Hospital with first time acute ischemic stroke were included in the study. Those with Previous history of TIA (Transient Ischemic Attack), CVA(Cerebro Vascular Accident),Patients on Thiazide diuretics, Patients with Malignancies, Patients who are a known case of gout or have clinical evidence of gout, Patients with chronic renal failure, Patients with hemorrhagic stroke are excluded from the study. Serum uric acid levels were measured within 24hours of onset of acute ischemic stroke. Cutoff value of Serum uric acid level was taken as 6.5mg/dl. Other risk factors including Diabetes Mellitus, Hypertension, CAD and hyperlipidemia are evaluated with appropriate lab investigations. The data is entered using MS Excel. Analysed using SPSS Version 16. Descriptive and Inferential statistical analysis done by Chi Square Test, Fisher’s Exact Test, p value less than 0.05 is taken as statistically significant. Results: In the study population 66% were male and 34% were female. 76% were hemiparetic and 24% were hemiplegic. 74% had serum uric acid ≤6.5mg/dl and 26% had serum uric acid levels >6.5mg/dl. The study revealed the strong association between the high serum uric acid levels and Cerebro Vascular Accident (p=0.000*), Diabetes Mellitus(p=0.007*), Systemic Hypertension(p=0.042*), Coronary Artery Disease(p=0.029*), elevated LDL(p=0.046*) and Total Cholesterol levels(p=0.002*). Conclusion: The study shows that uric acid levels may be considered as an independent predictor for ischemic stroke. SUA has a strong association with DM, SHT, CAD and elevated Cholesterol levels. Lowering of SUA level can be considered as one of the preventive modalities for stroke while treating high risk population.

Key Word: Serum Uric Acid, Acute ischemic stroke, anti-oxidant.

 

INTRODUCTION

The Framingham Heart Study was the first one to evaluate an association between elevated Serum Uric Acid(SUA) levels and cardiovascular disease outcome in general population. The study concluded that the association with cardiovascular disease merely reflects the link between SUA levels and other risk factors including hypertension, kidney disease, elevated lipoprotein levels and use of diuretics1. On the contrary several other epidemiological studies have shown elevated SUA levels to predict increased risk of cardiovascular events, hypertension, congestive heart failure and Type II diabetes mellitus. Increased SUA levels were found to be associated with increased risk of ischemic as well as hemorrhagic strokes. Higher SUA levels in stroke patients have also been described in association with improved or worse outcome1. One of the major sites where the anti-oxidant effects of uric acid have been proposed is in the central nervous system, particularly in conditions such as multiple sclerosis, Parkinson’s disease, and acute stroke. While chronic elevations in uric acid are associated with increased stroke risk, acute elevations in uric acid may provide some anti-oxidant protection. For example, uric acid protects cultured rat hippocampal neuronal cells from oxidative stress, and administration of uric acid 24 hours prior to middle artery occlusion also attenuated brain injury induced by acute ischemia in rats2.Therefore, the aim of the present study was to assess the serum UA levels in ischemic stroke and association with risk factors.

 

 

METHODOLOGY

This is an cross sectional study done at Government Royapettah Hospital, Chennai. After obtaining the official permission from Institutional Ethics Committee and informed consent from the patients, the study was conducted. The arrived sample size was 50. Simple random sampling done to arrive at the sample size. The Patients admitted in Govt. Royapettah Hospital with first time acute ischemic stroke were included in the study. Those with Previous H/o TIA, CVA, Patients on Thiazide diuretics, Patients with Malignancies, Patients who are a known case of gout or have clinical evidence of gout, Patients with chronic renal failure, Patients with hemorrhagic stroke are excluded from the study. Serum uric acid levels were measured within 24hrs of onset of acute ischemic stroke. Cutoff value of Serum uric acid level was taken as 6.5mg/dl. Other risk factors including DM, Hypertension, CAD and hyperlipidemia will be evaluated with appropriate lab investigations. The data is entered using MS Excel. Analysed using SPSS Version 16. Descriptive and Inferential statistical analysis done by Chi Square Test, Fisher’s Exact Test and p value less than 0.05 is taken as statistically significant.


 

RESULTS

Table 1: Descriptive Statistics of the Acute Ischemic Stroke Patients

Variables

Frequency

Percentage

Age group in years

40-50

4

8%

51-60

15

30%

61-70

21

42%

71-80

9

18%

>81

1

2%

Gender

Male

33

66%

Female

17

34%

DM

Yes

18

36%

No

32

64%

CAD

Yes

15

30%

No

35

70%

HT

Yes

19

38%

No

31

62%

CVA

Hemiparesis

38

76%

Hemiplegia

12

24%

Total Cholesterol

≤200mg/dl

43

86%

>200mg/dl

7

14%

LDL Cholesterol

≤100mg/dl

10

20%

>100mg/dl

40

80%

TGL

≤150mg/dl

45

90%

>150mg/dl

5

10%

 

Figure 1: Serum Uric acid Levels in Acute Ischemic Stroke Patients

 

Table 2: Association Between SUA level and CVA

Diseases

Serum Uric Acid Level

Statistical Test, Value

P Value

<=6.5mg/dl

>6.5mg/dl

CVA

Hemiparesis(38)

37(97.4%)

1(2.6%)

Fisher Exact Test,

44.047

0.000*

Hemiplegia(12)

0

12(100%)

*P value <0.05 is taken as statistically significant

 

Table 3: Association of Serum Uric Acid levels with risk factors of Acute Ischemic Stroke

Risk factors of CVA

Serum Uric Acid Level

Statistical Test, Value

P Value

≤6.5mg/dl

>6.5mg/dl

CAD

Yes(15)

8(53.3%)

7(46.7%)

Chi Square Test,

4.757

0.029*

No(35)

29(82.9%)

6(17.1%)

DM

Yes(18)

9(50%)

9(50%)

Fisher’s Exact Test,

8.252

0.007*

No(32)

28(87.5%)

4(12.5%)

HT

Yes(19)

11(57.9%)

8(42.1%)

Chi Square Test,

4.131

0.042*

No(31)

26(83.9%)

5(16.1%)

Total CHO

≤200mg/dl (42)

35(83.3%)

7(16.3%)

Fisher’s Exact Test,

11.647

0.002*

>200mg/dl (8)

2(25%)

6(75%)

LDL CHO

≤100mg/dl (10)

10(100%)

0(0%)

Fisher’s Exact Test,

4.304

0.046*

>100mg/dl (40)

27(67.5%)

13(32.5%)

TGL CHO

≤150mg/dl (45)

34(75.6%)

11(24.4%)

Fisher’s Exact Test,

0.555

0.595

>150mg/dl (5)

3(60%)

2(40%)

*P value <0.05 is taken as statistically significant

 


The study revealed the strong association between the high serum uric acid levels and Cerebro Vascular Accident (p=0.000*), and various risk factors like Diabetes Mellitus(p=0.007*), Systemic Hypertension(p=0.042*), Coronary Artery Disease(p=0.029*), elevated LDL(p=0.046*) and Total Cholesterol levels(p=0.002*).

 

DISCUSSION

The study molecule Serum uric acid(SUA) cause stimulation of renin-angiotensin-aldosterone system and may contribute to the development of CAD apart from development of renal vascular constriction. In this study, there was a significant increase in the serum uric acid levels in acute ischemic stroke patients and the elevated SUA levels are strongly associated with the risk factor Coronary Artery Disease which was similar to the findings of the study done by Zhang et al in 20143. In Diabetes Mellitus patients, SUA cause mitochondrial oxidative stress leads to fatty liver. This results in insulin resistance (IR) - Hepatic Effect; SUA in adipocytes promotes NADPH oxidase that cause lipid oxidation and release super oxide radicals, MCP1 and also reduces adiponectin. This results in increased IR and leptin overexpression in visceral fat-Adipose Effect. SUA cause reduced nitric oxide by blocking L-arginine results in IR and endothelial cell dysfunction- Vascular Effect SUA promote macrophage induced hyalinosis cause islet cell destruction by pro-inflammatory substances and results in type 2 DM- Islet Cell Effects. SUA block the ability of insulin to deliver glucose to skeletal muscle -Muscle effect. In this study the risk factor Diabetes Mellitus also has significant association with elevated SUA levels which was very similar to the study done by Bhole et al 20104 The increase in the prevalence of hyperuricemia cases and the accumulated evidence that hyperuricemia increases the risk for hypertension (HT) onset and lack of optimal blood pressure (BP) control. Hyperuricemia leads to the increase in BP values by stimulating oxidative stress and inflammatory mechanisms through endothelial dysfunction and proliferation of smooth muscle cells in the blood vessels and stimulation of the Renin-Angiotensin-Aldosterone-System. SUA also cause Arteriolar wall thickening leading to Hypertension. In this study, there is a significant association between the Hypertension status and the Elevated SUA levels which was very identical to the study done by Roxana et al 2018.5 This study shows similar results of study done by Devajit et al 20136 of significant association of elevated SUA levels with high Total Cholesterol. Due to the high prevalence of hyperuricemia in patients with acute stroke, and its accompanying increase in triglyceride and LDL cholesterol levels, it can be considered as a risk factor for acute stroke. In this study there was a strong association between Elevated LDL levels and elevated SUA levels and this study finding is similar to the study done by Masoud et al 20127. Serum uric acid, the strong anti oxidant, under certain circumstances like absence of other anti-oxidants may act as pro-oxidant. Thus serum uric acid may be taken as a marker of elevated risk of cerebrovascular accident. The NHANES study concluded that uric acid is an independent risk factor for development of cardiovascular and cerebrovascular diseases8. Weir et al 2003 who studied 3731 patients and measured serum urate in 2498 reported that elevated urate level predict a lower chance of good 90-day outcome independent of stroke severity and other prognostic factor9. Serum uric acid may have a direct role in the atherosclerotic process, because human atherosclerotic plaque contains more uric acid than do control arteries. Inflammation is one of the features of atherosclerosis, and uric acid crystals may induce inflammatory responses that are reduced by lipoproteins which have an ability to bind uric acid crystals. Hyperuricemia may also promote thrombus formation.10

 

CONCLUSION

This study shows that elevated SUA is strongly associated with an increased risk for the development of acute ischemic/ non-embolic stroke in this study population. SUA is the substance with both anti inflammatory and pro-inflammatory activity. Elevated SUA can be considered as one of the risk factors for acute ischemic non-embolic stroke and also it is found to be strongly associated with various risk factors of non-communicable diseases. Lowering of SUA level can be considered as one of the preventive modalities for stroke while treating high risk population. It is also suggested that further studies are required to assess whether lowering of SUA level with drugs can actually reduce the risk of ischemic stroke. SUA is associated with all the risk factors of cerebrovascular disease, this study could be used to support the evidence that serum uric acid may be used as a early marker for development of cerebrovascular disease

 

REFERENCES

  1. Koppula R, Kaul S, Rao AV, Jyothy A, Mphil AM. Association of serum uric acid level with ischemic stroke, stroke subtypes and clinical outcome [Internet]. [cited 2019 Mar 4]. Available from: http://www.neurology-asia.org/articles/neuroasia-2013-18(4)-349.pdf
  2. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids [Internet]. 2008 Jun [cited 2019 Mar 4];27(6):608–19. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18600514
  3. Zhang J, He L, Cao S, Yang Q, Yang S, Zhou Y. Association of serum uric acid and coronary artery disease in premenopausal women. PLoS One [Internet]. 2014 [cited 2019 Mar 4];9(9):e106130. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25184207
  4. Bhole V, Choi JWJ, Kim SW, de Vera M, Choi H. Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med [Internet]. 2010 Oct [cited 2019 Mar 4];123(10):957–61. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20920699
  5. Buzas R, Tautu O-F, Dorobantu M, Ivan V, Lighezan D. Serum uric acid and arterial hypertension-Data from Sephar III survey. PLoS One [Internet]. 2018 [cited 2019 Mar 4];13(7):e0199865. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29966019
  6. Sarmah D, Sharma B. A correlative study of uric acid with lipid profile. Asian J Med Sci [Internet]. 2013 May 12 [cited 2019 Mar 4];4(2):8–14. Available from: https://www.nepjol.info/index.php/AJMS/article/view/7893.
  7. Mehrpour M, Khuzan M, Najimi N, Motamed MR, Fereshtehnejad S-M. Serum uric acid level in acute stroke patients. Med J Islam Repub Iran [Internet]. 2012 May [cited 2019 Mar 4];26(2):66–72. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23483825
  8. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA [Internet]. 2000 May 10 [cited 2019 Mar 24];283(18):2404–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10815083
  9. Weir CJ, Muir SW, Walters MR, Lees KR. Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute Stroke. Stroke [Internet]. 2003 Aug [cited 2019 Mar 24];34(8):1951–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1284334
  10. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum Uric Acid Is a Strong Predictor of Stroke in Patients With Non–Insulin-Dependent Diabetes Mellitus. Stroke [Internet]. 1998 Mar [cited 2019 Mar 24];29(3):635–9. Available from: https://www.ahajournals.org/doi/10.1161/01.STR.29.3.635.

 








 



 







 








 


 


 



 



 

 


 





 



 






 





 



 



 



 




 

 


 


 









Policy for Articles with Open Access
Authors who publish with MedPulse International Journal of Anesthesiology (Print ISSN:2579-0900) (Online ISSN: 2636-4654) agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.